AstraZeneca Signs Massive US$8.5 B Oncology Collaboration with Merck & Co Following Trial Failure
By Daniel Roberts & Natasha Piper
Pharma Deals Review: Vol 2017 Issue 8 (Table of Contents)
Published: 16 Aug-2017
DOI: 10.3833/pdr.v2017.i8.2265 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
AstraZeneca (AZ) has signed a global oncology collaboration with Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS